136 related articles for article (PubMed ID: 9650454)
1. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia.
Matsue K; Itoh M; Tsukuda K; Kokubo T; Hirose Y
Int J Hematol; 1998 Apr; 67(3):319-29. PubMed ID: 9650454
[TBL] [Abstract][Full Text] [Related]
2. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus.
Abruzzo LV; Schmidt K; Weiss LM; Jaffe ES; Medeiros LJ; Sander CA; Raffeld M
Blood; 1993 Jul; 82(1):241-6. PubMed ID: 8391875
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
Brown HA; Macon WR; Kurtin PJ; Gibson LE
J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
[TBL] [Abstract][Full Text] [Related]
4. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
[TBL] [Abstract][Full Text] [Related]
5. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
[TBL] [Abstract][Full Text] [Related]
6. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.
Bräuninger A; Spieker T; Willenbrock K; Gaulard P; Wacker HH; Rajewsky K; Hansmann ML; Küppers R
J Exp Med; 2001 Oct; 194(7):927-40. PubMed ID: 11581315
[TBL] [Abstract][Full Text] [Related]
7. Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin's disease associated with Epstein-Barr virus.
Nakamura S; Sasajima Y; Koshikawa T; Kitoh K; Koike K; Motoori T; Ueda R; Mori S; Suchi T
Pathol Int; 1995 Dec; 45(12):958-64. PubMed ID: 8808302
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma.
Ohshima K; Takeo H; Kikuchi M; Kozuru M; Uike N; Masuda Y; Yoneda S; Takeshita M; Shibata T; Akamatsu M
Histopathology; 1994 Dec; 25(6):569-79. PubMed ID: 7698734
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis.
Martel P; Laroche L; Courville P; Larroche C; Wechsler J; Lenormand B; Delfau MH; Bodemer C; Bagot M; Joly P
Arch Dermatol; 2000 Jul; 136(7):881-6. PubMed ID: 10890990
[TBL] [Abstract][Full Text] [Related]
10. [Angioimmunoblastic T-cell lymphoma complicated with EBV-associated B-cell lymphoma].
Munemasa S; Sakai A; Sasaki N; Okikawa Y; Mihara K; Kimura A
Rinsho Ketsueki; 2005 Feb; 46(2):127-33. PubMed ID: 16447706
[TBL] [Abstract][Full Text] [Related]
11. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
12. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
Weiss LM; Jaffe ES; Liu XF; Chen YY; Shibata D; Medeiros LJ
Blood; 1992 Apr; 79(7):1789-95. PubMed ID: 1373088
[TBL] [Abstract][Full Text] [Related]
13. [Angioimmunoblastic lymphadenopathy and angioimmunoblastic T-cell lymphoma].
Li T; Gao D; Zhang B
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):99-101. PubMed ID: 9206215
[TBL] [Abstract][Full Text] [Related]
14. Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.
Shinohara A; Asai T; Izutsu K; Ota Y; Takeuchi K; Hangaishi A; Kanda Y; Chiba S; Motokura T; Kurokawa M
Leuk Lymphoma; 2007 Feb; 48(2):418-20. PubMed ID: 17325908
[No Abstract] [Full Text] [Related]
15. T cell-rich B cell lymphoma bearing Epstein-Barr virus in tumor cells: a case of IBL-T-like lesion following Lennert's lesion.
Wakatsuki S; Yumoto N; Takagi T; Kurosu K; Sakai C; Tamayama C; Komatsu T; Matsuzaki O; Mikata A
Pathol Int; 1995 Jun; 45(6):457-62. PubMed ID: 7581939
[TBL] [Abstract][Full Text] [Related]
16. Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
Huang J; Zhang PH; Gao YH; Qiu LG
Diagn Cytopathol; 2012 Apr; 40(4):346-51. PubMed ID: 21472868
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Anagnostopoulos I; Hummel M; Finn T; Tiemann M; Korbjuhn P; Dimmler C; Gatter K; Dallenbach F; Parwaresch MR; Stein H
Blood; 1992 Oct; 80(7):1804-12. PubMed ID: 1327284
[TBL] [Abstract][Full Text] [Related]
18. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Foss HD; Anagnostopoulos I; Herbst H; Grebe M; Ziemann K; Hummel M; Stein H
Blood; 1995 May; 85(10):2862-9. PubMed ID: 7742548
[TBL] [Abstract][Full Text] [Related]
19. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature.
Xu Y; McKenna RW; Hoang MP; Collins RH; Kroft SH
Am J Clin Pathol; 2002 Dec; 118(6):848-54. PubMed ID: 12472277
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV)-related lymphoproliferative disorder with subsequent EBV-negative T-cell lymphoma.
Tao Q; Srivastava G; Loke SL; Liang RH; Liu YT; Ho FC
Int J Cancer; 1994 Jul; 58(1):33-9. PubMed ID: 8014013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
